funny thing is you trade the chart, which is fine, but you assume the longs are worried or panicked about short term volatility. Truth is while you're trying to trade the momentum the longs here are investing in the fundamentals and any dip just presents buying opportunities for many of us
Most longs here understand the big picture value drivers and aren't worried about the daily stock swings. I'm personally here to see $25 before an exit and that will come with the completion of the Phase III trials next year. Between now and then I'll buy any dip below $5
good luck with your charting, I'll stick to the fundamentals
I would love to see an exit by 2014, but at the pace things are moving now I suspect we may see 2015 and still waiting patiently. Meet with FDA June 2013. 18 months for another phase 3 trial. 6 months for a meeting with FDA.
Agreed. I'll be adding to my position when the market opens on Monday. The thing I like about their lead drug is its molecular similarity to the naturally occurring hormone. On top of that, the similar mechanism of action to Linzess (and Linzess is FDA approved) supports the belief that Plecanatide will be safe AND effective.
beton--you're probably right,if the fundamentals are sound,it might be an opportunity.Unfortunately,I was involved in a feud with Indian .That's over and I won't be posting here anymore--good luck to you